SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3057One would imagine REGN would take a hit as well, I don't see why they wouldnFelix B-7/23/2020
3056Almost 80% of new programs (at ALNY) is with Regeneron!Miljenko Zuanic-7/23/2020
3055Alnylam/regeneron early stage... Nash, app, If app works, should be a brightBiotechwantabe-7/23/2020
3054From Roche, Lucentis 2Q-20 US sale was 341F (F=1.04$, 355 M), which are 12% loweMiljenko Zuanic-7/23/2020
3053It's unclear to me whether an implant requiring two (minor) surgeries per yeDewDiligence_on_SI17/22/2020
3052I am not sure what to think? If it was against Eylea it would be slam dunk...Felix B-7/22/2020
3051investorshub.advfn.comDewDiligence_on_SI-7/22/2020
3050RE: Dupi competitor, ABBV (upadacitinib) Second P3 AD data: prnewswire.com It aMiljenko Zuanic-7/21/2020
3049MDs liability and pts insurance is too high for any of them to continue using BeMiljenko Zuanic-7/21/2020
3048At this rate, NVS may end up withdrawing Beovu from the market.DewDiligence_on_SI-7/21/2020
3047From Novartis 2Q data, Lucentis ex-US sale decline significantly to $401M, whileMiljenko Zuanic17/21/2020
3046REGN did not disclose PK/PD data from (similar to CoV2) MERS-cocktail, but herMiljenko Zuanic-7/21/2020
3045I haven't found the vaccine front to closely but it seems like their nAb levFelix B-7/20/2020
3044OF Topic, CueVac CVnCoV Vaccine, dose levels of 2, 4 and 8 µg (Germany GovMiljenko Zuanic-7/20/2020
3043REGN CoV2-nAbs cocktail seems more and more desirable! Vaccines promise are not Miljenko Zuanic-7/20/2020
3042MK-1248 (Merck) ascopubs.org clinicaltrials.govMiljenko Zuanic-7/18/2020
3041Need to be anti-GITR agonist!Miljenko Zuanic-7/18/2020
3040How are the other GITR antibodies in the clinic doing?Felix B-7/18/2020
3039Gitr/libtayo clinicaltrials.gov Start mid SeptBiotechwantabe-7/17/2020
3038yes, <The agreement covers a fixed number of bulk lots that are intended to bMiljenko Zuanic-7/7/2020
3037investor.regeneron.com Round number $1000/dose for Barda. 450m/420k Must be sBiotechwantabe17/7/2020
3036investor.regeneron.com ...no single word on dose levels, dose range, sc versus iMiljenko Zuanic-7/6/2020
3035investor.regeneron.com biorxiv.org Moving to p2&3 indicates safety. MaybBiotechwantabe-7/6/2020
3034IL6 level is lower than in active RA, and sIL6R level (actual target in COVID) iMiljenko Zuanic-7/3/2020
3033Is a “Cytokine Storm” Relevant to COVID-19? jamanetwork.com "...Several earnigel bates17/3/2020
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News